Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Early research (Phase 1)Ended earlyNCT00004261What this trial is testingEF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue SarcomaWho this might be right forBreast CancerCervical CancerHead and Neck Cancer+2 more University Health Network, Toronto
Large-scale testing (Phase 3)Study completedNCT00008398What this trial is testingSargramostim in Decreasing Mucositis in Patients Receiving Radiation Therapy for Head and Neck CancerWho this might be right forHead and Neck CancerOral ComplicationsRadiation Toxicity Radiation Therapy Oncology Group
Testing effectiveness (Phase 2)Study completedNCT01469429What this trial is testingPhase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer.Who this might be right forMetastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaSalivary Gland Squamous Cell CarcinomaStage 0 Hypopharyngeal Cancer+55 more Ohio State University Comprehensive Cancer Center 70
Not applicableEnded earlyNCT03049358What this trial is testingOlfactory Training in Improving Sense of Smell After Radiation Therapy in Patients With Paranasal Sinus or Nasopharyngeal CancerWho this might be right forStage 0 Nasopharyngeal CarcinomaStage 0 Paranasal Sinus CancerStage I Nasopharyngeal Carcinoma+15 more Stanford University 15
Early research (Phase 1)Study completedNCT00978081What this trial is testingPhotodynamic Therapy in Treating Patients With Premalignant or Early Stage Head and Neck TumorsWho this might be right forHead and Neck CancerPrecancerous Condition Abramson Cancer Center at Penn Medicine 35
Testing effectiveness (Phase 2)Looking for participantsNCT06532279What this trial is testingTesting the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck CancerWho this might be right forClinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8+38 more NRG Oncology